Resources and Tools

Take advantage of the wide variety of resources that CSL Behring offers. Order educational materials about von Willebrand disease (VWD), access an award-winning website on VWD, or register for e-mail updates—and receive a book about VWD, with our compliments.

Request More Information
Sign up for e-mail updates and stay up-to-date on the latest news and research on von Willebrand disease (VWD) and Humate-P. Register now and you will receive the book, A Guide to Living With von Willebrand Disease. This book provides valuable information on living with the disease, and was written by a nurse who has VWD.

Patient Education Materials
For patients or parents, download or print helpful tools like a bleeding journal, or read an excerpt from A Guide to Living With von Willebrand Disease—the first book-length resource about VWD.

AllAboutBleeding.com
If you want to know more about VWD, this site offers additional information.

Glossary of Terms
Just what is vasoconstriction? Learn key terms related to VWD here

Important Safety Information

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized, Humate-P^® is indicated in adult patients for treatment and prevention of bleeding in hemophilia A (classical hemophilia). Humate-P^® is also indicated in adult and pediatric patients with von Willebrand disease (VWD) for (1) treatment of spontaneous and trauma-induced bleeding episodes, and (2) prevention of excessive bleeding during and after surgery. This applies to patients with severe VWD, and patients with mild and moderate VWD for whom use of desmopressin is known or suspected to be inadequate.

Humate-P^® is contraindicated in individuals with a history of anaphylactic or severe systemic response to antihemophilic factor or von Willebrand factor preparations or to any of its components.

Thromboembolic events have been reported in VWD patients receiving coagulation factor replacement, especially in the setting of known risk factors for thrombosis. Caution should be exercised and antithrombotic measures considered.

Humate-P^® is derived from human plasma. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Although few adverse reactions have been reported the most common are allergic-anaphylactic reactions, including urticaria, chest tightness, rash, pruritus, edema, shock, chills and fever, and hypervolemia. For patients undergoing surgery, the most common adverse reactions are postoperative wound or injection-site bleeding.

Please see accompanying full prescribing information for Humate-P^®.